Mina Umemoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mina Umemoto has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Takayuki Kanaseki
Department of Pathology Sapporo Medical University Sapporo Japan
39 shared publications - Tasuku Mariya
Department of Obstetrics and Gynecology, Sapporo Medical University School of Medicine, Sapporo, Japan
39 shared publications - Toshihiko Torigoe
Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan
39 shared publications - Tsuyoshi Saito
Department of Obstetrics & Gynecology, Sapporo Medical University, Sapporo, Japan
39 shared publications - Yoshihiko Hirohashi
Department of Pathology, Sapporo Medical University
39 shared publications - Shintaro Sugita
Department of Surgical Pathology Sapporo Medical University School of Medicine Sapporo Japan
38 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Fig. S2 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Fig. S2 | Sequences of the identified neoantigens.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig. S2 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Fig. S2 | Sequences of the identified neoantigens.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Fig. S11 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Fig. S11 | Characterization of a neoantigen-specific CD4+ TIL cluster.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig. S11 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Fig. S11 | Characterization of a neoantigen-specific CD4+ TIL cluster.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Fig. S1 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Fig. S1 | IHC of endometrial cancer tissues.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig. S1 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Fig. S1 | IHC of endometrial cancer tissues.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Fig. S5 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Fig. S5 | Characterization of neoantigen-specific CD4+ TIL clones.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig. S5 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Fig. S5 | Characterization of neoantigen-specific CD4+ TIL clones.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S1 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Table S1 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Table S1 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Fig. S8 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Fig. S8 | Cytokine production by neoantigen-specific CD4+ TIL clones.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig. S8 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Fig. S8 | Cytokine production by neoantigen-specific CD4+ TIL clones.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Fig. S10 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Fig. S10 | Characterization of neoantigen-reactive TCR clonotypes.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig. S10 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Fig. S10 | Characterization of neoantigen-reactive TCR clonotypes.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S4 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Table S4 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Table S4 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Fig. S4 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Fig. S4 | Neoantigen specificity of CD4+ TIL clones.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFig. S4 from Identification and Phenotypic Characterization of Neoantigen-Specific Cytotoxic CD4+ T Cells in Endometrial Cancer
Fig. S4 | Neoantigen specificity of CD4+ TIL clones.